<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Over a 12-year period, 112 consecutive children with arterial <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> (AIS) and 38 children with <z:hpo ids='HP_0005305'>cerebral venous thrombosis</z:hpo> (CVT) were prospectively recruited at a single pediatric center in Argentina </plain></SENT>
<SENT sid="1" pm="."><plain>One or more underlying clinical conditions were identified in most patients (55%) with AIS and in almost <z:hpo ids='HP_0000001'>all</z:hpo> patients with CVT </plain></SENT>
<SENT sid="2" pm="."><plain>Inherited and/or acquired prothrombotic disorders were detected in 17% of the patients with AIS and in 34% of the children with CVT </plain></SENT>
<SENT sid="3" pm="."><plain>No associations between factor V Leiden or prothrombin G20210A mutation and children with AIS or CVT were found </plain></SENT>
<SENT sid="4" pm="."><plain>Antithrombotic agents (i.e., aspirin, low-molecular-weight <z:chebi fb="5" ids="28304">heparin</z:chebi> and <z:chebi fb="0" ids="53766,53768,53769">acenocoumarol</z:chebi>) were administered without major hemorrhagic complications </plain></SENT>
<SENT sid="5" pm="."><plain>In our cohorts, mortality due to the thrombotic episode was 1.8% in children with AIS </plain></SENT>
<SENT sid="6" pm="."><plain>No child with CVT died from his or her thrombotic episodes </plain></SENT>
<SENT sid="7" pm="."><plain>Three children (3.2%) and 1 adolescent (1.1%) with AIS had thrombotic progression and recurrence, respectively </plain></SENT>
<SENT sid="8" pm="."><plain>A large percentage of children with AIS (68%) and CVT (32%) have had some kind of sequels that caused serious disability in approximately half the cases </plain></SENT>
</text></document>